Immunoassay Market

Immunoassay Market (Technology - Chemiluminescence Immunoassay (CLIA), Enzyme-linked Immunosorbent Assay (ELISA), Enzyme-linked Fluorescence Assay (ELFA), Radioimmunoassay (RIA); Product - Analyzer, Consumables; Application - Infectious Disease, Endocrinology, Oncology, Cardiology, Orthopedics; End use - Hospitals and Diagnostics Laboratories, Blood Banks) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Growing incidence of chronic and infectious diseases is anticipated to fuel demand for immunoassay. For example, as per a report published by the World Health Organization (WHO), in 2017, approximately 65 million individuals in the U.S. were diagnosed with Chronic Obstructive Pulmonary Disease (COPD). The factor is likely to boost regional immunoassay market.

Meanwhile, growing geriatric population across the world is anticipated to be a key driving factor for immunoassay market at global level. Owing to low immunity factor associated with old age, elderly population is more susceptible to chronic diseases and various infections.

Thus, most of diseases among arthritis, hypertension, diabetes, and dementia among others are diagnosed in elderly population.

For example, as per a report published by the United Nations, in 2017, the count of geriatric population was 962 million worldwide. The count is estimated to reach 2.1 billion by the end of 2050. This, in turn, is likely to pave potential opportunities for growth of the global immunoassay market.

Further, growing incidence of infectious diseases such as hepatitis, dengue, neurological disorders, and AIDS is a prominent factor projected to present tremendous opportunities for growth of immunoassay market over the forecast period (2018-2026).

For example, in 2017, as per data given by the WHO, approximately 5.8 million cases of severe dengue were identifies in Americans.

Rise in prevalence of such diseases is likely to provide lucrative opportunities for the prominent market players. In order to speed-up the diagnosis process, the companies operating in the global immunoassay market are focusing on development of novel immunoassay products.

The growth of the global immunoassay market largely depends on advancements in medical treatments and therapies. The healthcare industry is following a multifaceted route to cure and immunize patients against widespread infections and diseases. It is important for medical practitioners to understand the root causes of an infection in order to administer the right treatment line. Several diseases are related to the biochemical reactions going on inside the human body. Furthermore, the development of a seamless medical industry also calls for the study of biochemical reactions in the human body. There has been an increase in the incidence of infectious diseases in recent times. Medical practitioners mandate the use of macromolecular tests to understand the nature and type of disease or infection. The use of antibodies and antigens to conduct immunoassays has helped in increasing the rate of diagnosis across the medical and healthcare fraternities.

In this review, Transparency Market Research (TMR) uncovers a range of factors responsible for the growth and expansion of the global immunoassay market. The review elucidates the applications of immunoassays in key healthcare domains, creating new opportunities for market expansion. Furthermore, the segments pertaining to the immunoassay market have also been enunciated herein. It is worthwhile to understand that immunoassays can be used in various medical and healthcare verticals depending upon the type of requirement. Use of analytes, antigens, and antibodies for immunoassays has generated humongous opportunities the market players. The need for studying and quantifying analytes present in biological liquid samples such as urine or serum is felt across key domains. Immunoassays can help in achieving the aforementioned goal. The growth of the medical research fraternity across several regions shall be a launch pad for revenue generation across the market.

global immunoassay market

Use of Multiple Types of Immunoassay Markers

Medical practitioners study body proteins to analyse the reasons and causes behind the occurrence of a particular medical condition. Furthermore, the molecular composition of the human body is also analysed before administering a treatment line for critical infections. Several kinds of proteins and macromolecules can be studied through immunoassays. This factor has generated humongous opportunities for growth and expansion within the global immunoassay market. Medical professionals use several types of immunoassays that come in different formats. These immunoassays can be blended with certain reagents in order to enhance the performance of the former. Heterogeneous immunoassays have gained popularity across the medical industry. Physical measurements pertaining to immunoassays are under review, and favourable results could contribute to the growth of the market. The medical research industry is continually scouting for new technologies that can help in improving the performance of immunoassays. The application of protein-analysis in key domains within healthcare has played to the advantage of the immunoassay market.

Use of Immunoassays for Clinical Tests and Key Treatment Lines

The detection of analytes through immunoassays has helped the medical industry in fostering quality across primary treatment lines. Several types of clinical tests involve the use of immunoassay techniques, also known as immunodiagnostic tests. The use of immunoassays for pregnancy detection at home has emerged as an important driver of demand within the global market. Until a decade ago, there was widespread contention related to the accuracy of immunoassay tests. However, in recent times, the medical fraternity has acknowledged the use of immunoassay as medical markers. The use of immunoassay to measure insulin levels and diagnose heart diseases has also gained momentum in recent times. A number of pharmaceutical entities and research labs use immunoassay to test key compounds. On account of the factors mentioned herein, it is legit to expect that the global immunoassay market would grow at a sturdy pace in the times to follow.

Rising Incidence of Various Forms of Cancers

The use of immunoassays for diagnosing cancers has emerged as a vital driver of demand within the global market. The high incidence of cancer across several regional pockets has raised concerns across medical circles. Use of immunoassay for diagnosing prostate cancer has increased, mainly due to the ease of assessing prostate-specific antigens and hypoglycaemia through immunoassays. Over the course of the next decade, the total volume of revenues within the global immunoassay market is set to multiply. Assessment of heart disease can also be done with the help of specialised immunoassays.

Anti-Doping Analysis for Sportspersons

Doping is a severe crime in the sports fraternity, and sportspersons are required to steer clear and clean of doping tests. The consumption of restricted drugs and power boosters for sportspersons follows from several rules and regulations. Therefore, it is important to set up anti-doping analysis laboratories to test samples of players. The use of recombinant human growth hormone can result in increased power and skill in sportspersons. Therefore, medical professionals use immunoassays for conducting anti-doping tests. The demand graph of the global immunoassay market is set to escalate in the times to follow. The popularity of photoacoustic immunoassays is set to given an impetus to market growth and maturity.

The leading vendors operating in the global immunoassay market are focusing on developing multiple-marker technologies. The development of customized immunoassays that can help in diagnosing cancers, heart diseases, and other problems shall help market players in capturing new markets. The relevance of immunoassays across multiple medical domains shall propel sales across the market. Some of the leading players operating in the global immunoassay market are Dickinson and Company, Abbott Laboratories, Ortho Clinical Diagnostics, F. Hoffmann-La Roche Ltd., and Danaher Corporation.

The global Immunoassay market is segmented as follows:

Technology

  • Chemiluminescence Immunoassay (CLIA)
  • Enzyme-linked Immunoassay (ELISA)
  • Enzyme-linked Immunofluorescent Assay (ELFA)
  • Radioimmunoassay (RIA)
  • Others

Product

  • Analyzer
  • Consumables

Application

  • Infectious Disease
  • Endocrinology
  • Oncology
  • Cardiology
  • Orthopedics
  • Others

End-user

  • Hospitals and Diagnostics Laboratories
  • Blood Banks
  • Others

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

    Chapter 1  Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

    Chapter 2  Assumptions and Research Methodology

    Chapter 3  Executive Summary: Global Immunoassay Market                              

    Chapter 4  Market Overview
    4.1. Introduction
    4.2. Key Industry Developments

    Chapter 5  Market Dynamics
    5.1. Drivers
    5.2. Restraints
    5.3. Opportunities
    5.4. Key Trends
    5.5. Global Immunoassay Market Size (US$ Mn) Forecast, 2016–2026
    5.6. Global Immunoassay Market Outlook
    5.7. Industry Mergers & Acquisitions
    5.8. Automate Immunoassay Analyzer Volume
    5.9. Distributor Analysis
    5.10. Regulatory Assessments, by Key Country/Region
    5.11. Winning Imperatives

    Chapter 6  Global Immunoassay Market Analysis and Forecast, by Technology
    6.1. Key Findings 
    6.2. Introduction 
    6.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
           6.3.1. Chemiluminescence Immunoassay (CLIA) 
           6.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
           6.3.3. Enzyme-linked Fluorescent Assay (ELFA)
           6.3.4. Radioimmunoassay (RIA)
           6.3.5. Others ( Microarray, Immunofluorescence Assay Biochip Assay, Counting Immunoassay) 
    6.4. Market Attractiveness Analysis, by Technology

    Chapter 7  Global Immunoassay Market Analysis and Forecast, by Product
    7.1. Key Findings 
    7.2. Introduction 
    7.3. Market Size (US$ Mn) Forecast, by Product, 2018–2026
           7.3.1. Analyzer 
           7.3.2. Consumables 
    7.4. Market Attractiveness Analysis, by Product

    Chapter 8  Global Immunoassay Market Analysis and Forecast, by Application
    8.1. Key Findings 
    8.2. Introduction 
    8.3. Market Size (US$ Mn) Forecast, by Application, 2018–2026
           8.3.1. Infectious Disease
           8.3.2. Endocrinology
           8.3.3. Oncology
           8.3.4. Cardiology
           8.3.5. Orthopedics
           8.3.6. Others (Autoimmune Disorders, Allergy, Therapeutic Drug Monitoring, Liver Diseases, Acid Base Tests, GI Stool Testing, etc.) 
    8.4. Market Attractiveness Analysis, by Application

    Chapter 9  Global Immunoassay Market  Analysis and Forecasts, by End-user
    9.1. Key Findings
    9.2. Market Size (US$ Mn) Forecast, by End-user, 2018–2026
           9.2.1. Hospitals and Diagnostics Laboratories
           9.2.2. Blood Banks
           9.2.3. Others (Academic & Research Institutes, Pharmaceutical & Biotech Companies)
    9.3. Market Attractiveness Analysis, by End-user

    Chapter 10  Global Immunoassay Market Analysis and Forecasts, by Region
    10.1.  Key Findings
    10.2.  Global Market Scenario
    10.3. Market Value (US$ Mn) Forecast, by Region, 2018–2026
           10.3.1. North America
           10.3.2. Europe
           10.3.3. Asia Pacific 
           10.3.4. Latin America
           10.3.5. Middle East & Africa
    10.4. Market Attractiveness Analysis, by Region
    10.5. Key Trends, by Region

    Chapter 11  North America Immunoassay  Market  Analysis and Forecast
    11.1. Market Overview
    11.2. Market Size  (US$ Mn) Forecast, by Country, 2018–2026
           11.2.1. U.S.
           11.2.2. Canada
    11.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
           11.3.1. Chemiluminescence Immunoassay (CLIA) 
           11.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
           11.3.3. Enzyme Linked Fluorescent Assay (ELFA)
           11.3.4. Radioimmunoassay (RIA)
           11.3.5. Others 
    11.4. Market Size (US$ Mn) Forecast, by Product, 2018–2026
           11.4.1. Analyzers
           11.4.2. Consumables
    11.5.  Market Size (US$ Mn) Forecast, by Application, 2018–2026
           11.5.1. Infectious Disease
           11.5.2. Endocrinology
           11.5.3. Oncology
           11.5.4. Cardiology
           11.5.5. Orthopedics
           11.5.6. Others 
    11.6. Market Size (US$ Mn) Forecast, by End-user, 2018–2026
           11.6.1. Hospitals and Diagnostics Laboratories
           11.6.2. Blood Banks
           11.6.3. Others
    11.7. Market Attractiveness Analysis 
           11.7.1. By Country
           11.7.2. By Technology
           11.7.3. By Product
           11.7.4. By Application
           11.7.5. By End-user

    Chapter 12  Europe Immunoassay  market  Analysis and Forecast
    12.1. Market Overview
    12.2. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2026
           12.2.1. U.K.
           12.2.2. Germany
           12.2.3. France
           12.2.4. Italy
           12.2.5. Spain
           12.2.6. Rest of Europe
    12.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
           12.3.1. Chemiluminescence Immunoassay (CLIA) 
           12.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
           12.3.3. Enzyme Linked Fluorescent Assay (ELFA)
           12.3.4. Radioimmunoassay (RIA)
           12.3.5. Others 
    12.4. Market Size (US$ Mn) Forecast, by Product, 2018–2026
           12.4.1. Analyzers
           12.4.2. Consumables
    12.5.  Market Size (US$ Mn) Forecast, by Application, 2018–2026
           12.5.1. Infectious Disease
           12.5.2. Endocrinology
           12.5.3. Oncology
           12.5.4. Cardiology
           12.5.5. Orthopedics
           12.5.6. Others 
    12.6. Market Size (US$ Mn) Forecast, by End-user, 2018–2026
           12.6.1. Hospitals and Diagnostics Laboratories
           12.6.2. Blood Banks
           12.6.3. Others
    12.7. Market Attractiveness Analysis 
           12.7.1. By Country
           12.7.2. By Technology
           12.7.3. By Product
           12.7.4. By Application
           12.7.5. By End-user

    Chapter 13  Asia Pacific Immunoassay Market Analysis and Forecast
    13.1. Market Overview
    13.2. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2026
           13.2.1. China
           13.2.2. India
           13.2.3. Japan
           13.2.4. Australia & New Zealand
           13.2.5. Rest of Asia Pacific
    13.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
           13.3.1. Chemiluminescence Immunoassay (CLIA) 
           13.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
           13.3.3. Enzyme Linked Fluorescent Assay (ELFA)
           13.3.4. Radioimmunoassay (RIA)
           13.3.5. Others 
    13.4. Market Size (US$ Mn) Forecast, by Product, 2018–2026
           13.4.1. Analyzers
           13.4.2. Consumables
    13.5.  Market Size (US$ Mn) Forecast, by Application, 2018–2026
           13.5.1. Infectious Disease
           13.5.2. Endocrinology
           13.5.3. Oncology
           13.5.4. Cardiology
           13.5.5. Orthopedics
           13.5.6. Others 
    13.6. Market size (US$ Mn) Forecast, by End-user, 2018–2026
           13.6.1. Hospitals and Diagnostics Laboratories
           13.6.2. Blood Banks
           13.6.3. Others
    13.7. Market Attractiveness Analysis 
           13.7.1. By Country
           13.7.2. By Technology
           13.7.3. By Product
           13.7.4. By Application
           13.7.5. By End-user

    Chapter 14  Latin America Immunoassay Market Analysis and Forecast
    14.1. Market Overview
    14.2. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2026
           14.2.1. Brazil
           14.2.2. Mexico
           14.2.3. Rest of Latin America
    14.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
           14.3.1. Chemiluminescence Immunoassay (CLIA) 
           14.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
           14.3.3. Enzyme Linked Fluorescent Assay (ELFA)
           14.3.4. Radioimmunoassay (RIA)
           14.3.5. Others 
    14.4. Market Size (US$ Mn) Forecast, by Product, 2018–2026
           14.4.1. Analyzers
           14.4.2. Consumables
    14.5.  Market Size (US$ Mn) Forecast, by Application, 2018–2026
           14.5.1. Infectious Disease
           14.5.2. Endocrinology
           14.5.3. Oncology
           14.5.4. Cardiology
           14.5.5. Orthopedics
           14.5.6. Others 
    14.6. Market Size (US$ Mn) Forecast, by End-user, 2018–2026
           14.6.1. Hospitals and Diagnostics Laboratories
           14.6.2. Blood Banks
           14.6.3. Others
    14.7. Market Attractiveness Analysis 
           14.7.1. By Country
           14.7.2. By Technology
           14.7.3. By Product
           14.7.4. By Application
           14.7.5. By End-user

    Chapter 15  Middle East and Africa Immunoassay Market Analysis and Forecast
    15.1. Market Overview
    15.2. Market size (US$ Mn) Forecast, by Country/Sub-region, 2018–2026
           15.2.1. GCC Countries
           15.2.2. South Africa
           15.2.3. Rest of Middle East and Africa
    15.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
           15.3.1. Chemiluminescence Immunoassay (CLIA) 
           15.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
           15.3.3. Enzyme Linked Fluorescent Assay (ELFA)
           15.3.4. Radioimmunoassay (RIA)
           15.3.5. Others 
    15.4. Market Size (US$ Mn) Forecast, by Product, 2018–2026
           15.4.1. Analyzers
           15.4.2. Consumables
    15.5.  Market Size (US$ Mn) Forecast, by Application, 2018–2026
           15.5.1. Infectious Disease
           15.5.2. Endocrinology
           15.5.3. Oncology
           15.5.4. Cardiology
           15.5.5. Orthopedics
           15.5.6. Others 
    15.6. Market Size (US$ Mn) Forecast, by End-user, 2018–2026
           15.6.1. Hospitals and Diagnostics Laboratories
           15.6.2. Blood Banks
           15.6.3. Others
    15.7. Market Attractiveness Analysis 
           15.7.1. By Country
           15.7.2. By Technology
           15.7.3. By Product
           15.7.4. By Application
           15.7.5. By End-user

    Chapter 16  Competition Landscape
    16.1. Global Immunoassay Market Share, by Company, 2017
    16.2. Market Player – Competition Matrix (By Tier and Size of Companies)
    16.3. Company Profiles
           16.3.1. F. Hoffmann-La Roche Ltd.
                     16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.1.2. Product Portfolio
                     16.3.1.3. SWOT Analysis
                     16.3.1.4. Financial Overview
                     16.3.1.5. Strategic Overview
           16.3.2. Danaher Corporation.  
                     16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.2.2. Product Portfolio
                     16.3.2.3. SWOT Analysis
                     16.3.2.4. Financial Overview
                     16.3.2.5. Strategic Overview
           16.3.3. Abbott Laboratories.
                     16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.3.2. Product Portfolio
                     16.3.3.3. SWOT Analysis
                     16.3.3.4. Financial Overview
                     16.3.3.5. Strategic Overview
           16.3.4. Siemens Healthineers (Siemens AG)
                     16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.4.2. Product Portfolio
                     16.3.4.3. SWOT Analysis
                     16.3.4.4. Financial Overview
                     16.3.4.5. Strategic Overview
           16.3.5. DiaSorin S.p.A.
                     16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.5.2. Product Portfolio
                     16.3.5.3. SWOT Analysis
                     16.3.5.4. Financial Overview
                     16.3.5.5. Strategic Overview
           16.3.6. Sysmex Corporation.
                     16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.6.2. Product Portfolio
                     16.3.6.3. SWOT Analysis
                     16.3.6.4. Financial Overview
                     16.3.6.5. Strategic Overview
           16.3.7. bioMérieux SA 
                     16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.7.2. Product Portfolio
                     16.3.7.3. SWOT Analysis
                     16.3.7.4. Financial Overview
                     16.3.7.5. Strategic Overview
           16.3.8. Ortho Clinical Diagnostics (a part of Carlyle Group).
                     16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.8.2. Product Portfolio
                     16.3.8.3. SWOT Analysis
                     16.3.8.4. Financial Overview
                     16.3.8.5. Strategic Overview
           16.3.9. Thermo Fisher Scientific, Inc.
                     16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.9.2. Product Portfolio
                     16.3.9.3. SWOT Analysis
                     16.3.9.4. Financial Overview
                     16.3.9.5. Strategic Overview
           16.3.10. Becton, Dickinson and Company.
                     16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.10.2. Product Portfolio
                     16.3.10.3. SWOT Analysis
                     16.3.10.4. Financial Overview
                     16.3.10.5. Strategic Overview
           16.3.11. Merck KGaA.
                     16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.11.2. Product Portfolio
                     16.3.11.3. SWOT Analysis
                     16.3.11.4. Financial Overview
                     16.3.11.5. Strategic Overview

    List of Tables

    Table 01: Global Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
    Table 02: Global Immunoassay Market Size (US$ Mn) Forecast, by Product, 2016–2026
    Table 03: Global Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 04: Global Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2016–2026
    Table 05: Global Immunoassay Market Size (US$ Mn) Forecast, by Region, 2016–2026
    Table 06: North America Immunoassay Market Value (US$ Mn) Forecast, by Country, 2016–2026
    Table 07: North America Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
    Table 08: North America Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 09: North America Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 10: North America Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 11: U.S. Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
    Table 12: U.S. Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 13: U.S. Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 14: U.S. Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 15: Canada Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
    Table 16: Canada Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 17: Canada Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 18: Canada Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 19: Europe Immunoassay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 20: Europe Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
    Table 21: Europe Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 22: Europe Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 23: Europe Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 24: Germany Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
    Table 25: Germany Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 26: Germany Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 27: Germany Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 28: U.K. Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
    Table 29: U.K. Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 30: U.K. Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 31: U.K. Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 32: France Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
    Table 33: France Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 34: France Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 35: France Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 36: Italy Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
    Table 37: Italy Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 38: Italy Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 39: Italy Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 40: Spain Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
    Table 41: Spain Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 42: Spain Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 43: Spain Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 44: Asia Pacific Immunoassay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 45: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
    Table 46: Asia Pacific Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 47: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 48: Asia Pacific Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 49: China Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
    Table 50: China Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 51: China Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 52: China Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 53: India Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
    Table 54: India Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 55: India Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 56: India Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 57: Japan Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
    Table 58: Japan Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 59: Japan Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 60: Japan Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 61: Australia & New Zealand Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
    Table 62: Australia & New Zealand Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 63: Australia & New Zealand Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 64: Australia & New Zealand Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 65: Latin America Immunoassay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 66: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
    Table 67: Latin America Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 68: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 69: Latin America Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 70: Brazil Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
    Table 71: Brazil Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 72: Brazil Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 73: Brazil Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 74: Mexico Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
    Table 75: Mexico Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 76: Mexico Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 77: Mexico Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 78: Middle East & Africa Immunoassay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 79: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
    Table 80: Middle East & Africa Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 81: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 82: Middle East & Africa Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 83: GCC Countries Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
    Table 84: GCC Countries Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 85: GCC Countries Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 86: GCC Countries Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 87: South Africa Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
    Table 88: South Africa Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 89: South Africa Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 90: South Africa Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026

    List of Figures

    Figure 01: Global Immunoassay Market Size (US$ Mn) Forecast, 2016–2026
    Figure 03: Market Value Share, by Technology (2017)
    Figure 04: Market Value Share, by Product (2017)
    Figure 04: Market Value Share, by End-user (2017)
    Figure 03: Market Value Share, by Application (2017)
    Figure 04: Market Value Share, by Region (2017)
    Figure 07: Global Immunoassay Market Value Share Analysis (US$ Mn), by Technology, 2017 and 2026
    Figure 08: Global Immunoassay Market Attractiveness Analysis, by Technology, 2018–2026
    Figure 09: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chemiluminescence Immunoassay, 2016–2026
    Figure 10: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Enzyme-linked Immunosorbent Assay, 2016–2026
    Figure 11: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Enzyme Linked Fluorescent Assay, 2016–2026
    Figure 12: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Radioimmunoassay, 2016–2026
    Figure 13: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
    Figure 14: Global Immunoassay Market Value Share Analysis (US$ Mn), by Product, 2017 and 2026
    Figure 15: Global Immunoassay Market Attractiveness Analysis, by Product, 2018–2026
    Figure 16: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Analyzer, 2016–2026
    Figure 17: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Consumables, 2016–2026
    Figure 18: Global Immunoassay Market Value Share Analysis (US$ Mn), by Application, 2017 and 2026
    Figure 19: Global Immunoassay Market Attractiveness Analysis, by Application, 2018–2026
    Figure 20: Global Immunoassay Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Infectious Disease, 2016–2026
    Figure 21: Global Immunoassay Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oncology, 2015–2025
    Figure 22: Global Immunoassay Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oncology, 2016–2026
    Figure 23: Global Immunoassay Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Cardiology, 2016–2026
    Figure 24: Global Immunoassay Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Orthopedics, 2016–2026
    Figure 25: Global Immunoassay Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016–2026
    Figure 26: Global Immunoassay Market Value Share Analysis (US$ Mn), by End-user, 2017 and 2026
    Figure 27: Global Immunoassay Market Attractiveness Analysis, by End-user, 2018–2026
    Figure 28: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals & Diagnostic Laboratories, 2016–2026
    Figure 29: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood Banks, 2016–2026
    Figure 30: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
    Figure 31: Global Immunoassay Market Value Share Analysis, by Region, 2017 and 2026 
    Figure 32: Global Immunoassay Market Attractiveness Analysis, by Region, 2018–2026
    Figure 33: North America Immunoassay Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2026
    Figure 34: North America Immunoassay Market Value Share Analysis (US$ Mn), by Country, 2017 and 2026
    Figure 35: North America Immunoassay Market Attractiveness Analysis, by Country, 2018–2026
    Figure 36: North America Immunoassay Market Value Share, by Technology, 2017 and 2025
    Figure 37: North America Immunoassay Market Attractiveness, by Technology, 2018–2026
    Figure 38: North America Immunoassay Market Value Share, by Product, 2017 and 2026
    Figure 39: North America Immunoassay Market Attractiveness, by Product, 2018–2026
    Figure 40: North America Immunoassay Market Value Share, by Application, 2017 and 2026
    Figure 41: North America Immunoassay Market Attractiveness, by Application, 2018–2026
    Figure 42: North America Immunoassay Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 43: North America Immunoassay Market Attractiveness Analysis, by End-user, 2018–2026
    Figure 44: Europe Immunoassay Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2026
    Figure 45: Europe Immunoassay Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2017 and 2026
    Figure 46: Europe Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
    Figure 47: Europe Immunoassay Market Value Share, by Technology, 2017 and 2025
    Figure 48: Europe Immunoassay Market Attractiveness, by Technology, 2018–2026
    Figure 49: Europe Immunoassay Market Value Share, by Product, 2017 and 2026
    Figure 50: Europe Immunoassay Market Attractiveness, by Product, 2018–2026
    Figure 51: Europe Immunoassay Market Value Share, by Application, 2017 and 2026
    Figure 52: Europe Immunoassay Market Attractiveness, by Application, 2018–2026
    Figure 53: Europe Immunoassay Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 54: Europe Immunoassay Market Attractiveness Analysis, by End-user, 2018–2026
    Figure 55: Asia Pacific Immunoassay Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2026
    Figure 56: Asia Pacific Immunoassay Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2017 and 2026
    Figure 57: Asia Pacific Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
    Figure 58: Asia Pacific Immunoassay Market Value Share, by Technology, 2017 and 2025
    Figure 59: Asia Pacific Immunoassay Market Attractiveness, by Technology, 2018–2026
    Figure 60: Asia Pacific Immunoassay Market Value Share, by Product, 2017 and 2026
    Figure 61: Asia Pacific Immunoassay Market Attractiveness, by Product, 2018–2026
    Figure 62: Asia Pacific Immunoassay Market Value Share, by Application, 2017 and 2026
    Figure 63: Asia Pacific Immunoassay Market Attractiveness, by Application, 2018–2026
    Figure 64: Asia Pacific Immunoassay Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 65: Asia Pacific Immunoassay Market Attractiveness Analysis, by End-user, 2018–2026
    Figure 66: Latin America Immunoassay Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2026
    Figure 67: Latin America Immunoassay Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2017 and 2026
    Figure 68: Latin America Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
    Figure 69: Latin America Immunoassay Market Value Share, by Technology, 2017 and 2025
    Figure 70: Latin America Immunoassay Market Attractiveness, by Technology, 2018–2026
    Figure 71: Latin America Immunoassay Market Value Share, by Product, 2017 and 2026
    Figure 72: Latin America Immunoassay Market Attractiveness, by Product, 2018–2026
    Figure 73: Latin America Immunoassay Market Value Share, by Application, 2017 and 2026
    Figure 74: Latin America Immunoassay Market Attractiveness, by Application, 2018–2026
    Figure 75: Latin America Immunoassay Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 76: Latin America Immunoassay Market Attractiveness Analysis, by End-user, 2018–2026
    Figure 77: Middle East & Africa Immunoassay Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2026
    Figure 78: Middle East & Africa Immunoassay Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2017 and 2026
    Figure 79: Middle East & Africa Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
    Figure 80: Middle East & Africa Immunoassay Market Value Share, by Technology, 2017 and 2025
    Figure 81: Middle East & Africa Immunoassay Market Attractiveness, by Technology, 2018–2026
    Figure 82: Middle East & Africa Immunoassay Market Value Share, by Product, 2017 and 2026
    Figure 83: Middle East & Africa Immunoassay Market Attractiveness, by Product, 2018–2026
    Figure 84: Middle East & Africa Immunoassay Market Value Share, by Application, 2017 and 2026
    Figure 85: Middle East & Africa Immunoassay Market Attractiveness, by Application, 2018–2026
    Figure 86: Middle East & Africa Immunoassay Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 87: Middle East & Africa Immunoassay Market Attractiveness Analysis, by End-user, 2018–2026
    Figure 88: Global Immunoassay Market Share Analysis, by Company (2017)

Copyright © Transparency Market Research, Inc. All Rights reserved